Evaluation of New Folate Receptor-mediated Mitoxantrone Targeting Liposomes In vitro
CONCLUSION: By modifying folic acid on the surface of liposomes, tumor cells with high expression of folic acid receptors can be effectively targeted, thereby increasing the enrichment of intracellular drugs and improving efficacy. It can also change the delivery pathway, increase the amount of drug entering resistant tumor cells, and overcome resistance.PMID:37957921 | DOI:10.2174/0113892010258845231101091359 (Source: Current Pharmaceutical Biotechnology)
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Tianjiao Wen Yuan Gao Ying Zheng Bin Shan Cong Song Yahui An Jingxia Cui Source Type: research

Empowering the Battle: Bioenhancers as Allies against Cancer Drug Resistance
CONCLUSION: Bioenhancers when combined with drugs can elicit pharmacological activity. They are generally combined with therapeutic agents at low doses, which increase the BA or therapeutic activity of active pharmaceutical ingredient (API). This review sheds light on the synthesis and classification of bio-enhancers. It also discusses different applications of bio-enhancers like piperine, ginger, quercetin, curcumin, etc. in the treatment of cancer. The review also presents some of the recent advancements in terms of nanocarriers for delivering API combined with bioenhancers.PMID:37957922 | DOI:10.2174/0113892010192038231...
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Pratiksha Vasant Jadhav Naga Jothi Prasath Saurabh Gajbhiye Utkarsha Rane Tejas Girish Agnihotri Shyam Sudhakar Gomte Aakanchha Jain Source Type: research

Evaluation of New Folate Receptor-mediated Mitoxantrone Targeting Liposomes In vitro
CONCLUSION: By modifying folic acid on the surface of liposomes, tumor cells with high expression of folic acid receptors can be effectively targeted, thereby increasing the enrichment of intracellular drugs and improving efficacy. It can also change the delivery pathway, increase the amount of drug entering resistant tumor cells, and overcome resistance.PMID:37957921 | DOI:10.2174/0113892010258845231101091359 (Source: Current Pharmaceutical Biotechnology)
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Tianjiao Wen Yuan Gao Ying Zheng Bin Shan Cong Song Yahui An Jingxia Cui Source Type: research

Empowering the Battle: Bioenhancers as Allies against Cancer Drug Resistance
CONCLUSION: Bioenhancers when combined with drugs can elicit pharmacological activity. They are generally combined with therapeutic agents at low doses, which increase the BA or therapeutic activity of active pharmaceutical ingredient (API). This review sheds light on the synthesis and classification of bio-enhancers. It also discusses different applications of bio-enhancers like piperine, ginger, quercetin, curcumin, etc. in the treatment of cancer. The review also presents some of the recent advancements in terms of nanocarriers for delivering API combined with bioenhancers.PMID:37957922 | DOI:10.2174/0113892010192038231...
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Pratiksha Vasant Jadhav Naga Jothi Prasath Saurabh Gajbhiye Utkarsha Rane Tejas Girish Agnihotri Shyam Sudhakar Gomte Aakanchha Jain Source Type: research

Evaluation of New Folate Receptor-mediated Mitoxantrone Targeting Liposomes In vitro
CONCLUSION: By modifying folic acid on the surface of liposomes, tumor cells with high expression of folic acid receptors can be effectively targeted, thereby increasing the enrichment of intracellular drugs and improving efficacy. It can also change the delivery pathway, increase the amount of drug entering resistant tumor cells, and overcome resistance.PMID:37957921 | DOI:10.2174/0113892010258845231101091359 (Source: Current Pharmaceutical Biotechnology)
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Tianjiao Wen Yuan Gao Ying Zheng Bin Shan Cong Song Yahui An Jingxia Cui Source Type: research

Empowering the Battle: Bioenhancers as Allies against Cancer Drug Resistance
CONCLUSION: Bioenhancers when combined with drugs can elicit pharmacological activity. They are generally combined with therapeutic agents at low doses, which increase the BA or therapeutic activity of active pharmaceutical ingredient (API). This review sheds light on the synthesis and classification of bio-enhancers. It also discusses different applications of bio-enhancers like piperine, ginger, quercetin, curcumin, etc. in the treatment of cancer. The review also presents some of the recent advancements in terms of nanocarriers for delivering API combined with bioenhancers.PMID:37957922 | DOI:10.2174/0113892010192038231...
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Pratiksha Vasant Jadhav Naga Jothi Prasath Saurabh Gajbhiye Utkarsha Rane Tejas Girish Agnihotri Shyam Sudhakar Gomte Aakanchha Jain Source Type: research

Evaluation of New Folate Receptor-mediated Mitoxantrone Targeting Liposomes In vitro
CONCLUSION: By modifying folic acid on the surface of liposomes, tumor cells with high expression of folic acid receptors can be effectively targeted, thereby increasing the enrichment of intracellular drugs and improving efficacy. It can also change the delivery pathway, increase the amount of drug entering resistant tumor cells, and overcome resistance.PMID:37957921 | DOI:10.2174/0113892010258845231101091359 (Source: Current Pharmaceutical Biotechnology)
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Tianjiao Wen Yuan Gao Ying Zheng Bin Shan Cong Song Yahui An Jingxia Cui Source Type: research

Empowering the Battle: Bioenhancers as Allies against Cancer Drug Resistance
CONCLUSION: Bioenhancers when combined with drugs can elicit pharmacological activity. They are generally combined with therapeutic agents at low doses, which increase the BA or therapeutic activity of active pharmaceutical ingredient (API). This review sheds light on the synthesis and classification of bio-enhancers. It also discusses different applications of bio-enhancers like piperine, ginger, quercetin, curcumin, etc. in the treatment of cancer. The review also presents some of the recent advancements in terms of nanocarriers for delivering API combined with bioenhancers.PMID:37957922 | DOI:10.2174/0113892010192038231...
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Pratiksha Vasant Jadhav Naga Jothi Prasath Saurabh Gajbhiye Utkarsha Rane Tejas Girish Agnihotri Shyam Sudhakar Gomte Aakanchha Jain Source Type: research

Evaluation of New Folate Receptor-mediated Mitoxantrone Targeting Liposomes In vitro
CONCLUSION: By modifying folic acid on the surface of liposomes, tumor cells with high expression of folic acid receptors can be effectively targeted, thereby increasing the enrichment of intracellular drugs and improving efficacy. It can also change the delivery pathway, increase the amount of drug entering resistant tumor cells, and overcome resistance.PMID:37957921 | DOI:10.2174/0113892010258845231101091359 (Source: Current Pharmaceutical Biotechnology)
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Tianjiao Wen Yuan Gao Ying Zheng Bin Shan Cong Song Yahui An Jingxia Cui Source Type: research

Empowering the Battle: Bioenhancers as Allies against Cancer Drug Resistance
CONCLUSION: Bioenhancers when combined with drugs can elicit pharmacological activity. They are generally combined with therapeutic agents at low doses, which increase the BA or therapeutic activity of active pharmaceutical ingredient (API). This review sheds light on the synthesis and classification of bio-enhancers. It also discusses different applications of bio-enhancers like piperine, ginger, quercetin, curcumin, etc. in the treatment of cancer. The review also presents some of the recent advancements in terms of nanocarriers for delivering API combined with bioenhancers.PMID:37957922 | DOI:10.2174/0113892010192038231...
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Pratiksha Vasant Jadhav Naga Jothi Prasath Saurabh Gajbhiye Utkarsha Rane Tejas Girish Agnihotri Shyam Sudhakar Gomte Aakanchha Jain Source Type: research

Evaluation of New Folate Receptor-mediated Mitoxantrone Targeting Liposomes In vitro
CONCLUSION: By modifying folic acid on the surface of liposomes, tumor cells with high expression of folic acid receptors can be effectively targeted, thereby increasing the enrichment of intracellular drugs and improving efficacy. It can also change the delivery pathway, increase the amount of drug entering resistant tumor cells, and overcome resistance.PMID:37957921 | DOI:10.2174/0113892010258845231101091359 (Source: Current Pharmaceutical Biotechnology)
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Tianjiao Wen Yuan Gao Ying Zheng Bin Shan Cong Song Yahui An Jingxia Cui Source Type: research

Empowering the Battle: Bioenhancers as Allies against Cancer Drug Resistance
CONCLUSION: Bioenhancers when combined with drugs can elicit pharmacological activity. They are generally combined with therapeutic agents at low doses, which increase the BA or therapeutic activity of active pharmaceutical ingredient (API). This review sheds light on the synthesis and classification of bio-enhancers. It also discusses different applications of bio-enhancers like piperine, ginger, quercetin, curcumin, etc. in the treatment of cancer. The review also presents some of the recent advancements in terms of nanocarriers for delivering API combined with bioenhancers.PMID:37957922 | DOI:10.2174/0113892010192038231...
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Pratiksha Vasant Jadhav Naga Jothi Prasath Saurabh Gajbhiye Utkarsha Rane Tejas Girish Agnihotri Shyam Sudhakar Gomte Aakanchha Jain Source Type: research

Evaluation of New Folate Receptor-mediated Mitoxantrone Targeting Liposomes In vitro
CONCLUSION: By modifying folic acid on the surface of liposomes, tumor cells with high expression of folic acid receptors can be effectively targeted, thereby increasing the enrichment of intracellular drugs and improving efficacy. It can also change the delivery pathway, increase the amount of drug entering resistant tumor cells, and overcome resistance.PMID:37957921 | DOI:10.2174/0113892010258845231101091359 (Source: Current Pharmaceutical Biotechnology)
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Tianjiao Wen Yuan Gao Ying Zheng Bin Shan Cong Song Yahui An Jingxia Cui Source Type: research

Empowering the Battle: Bioenhancers as Allies against Cancer Drug Resistance
CONCLUSION: Bioenhancers when combined with drugs can elicit pharmacological activity. They are generally combined with therapeutic agents at low doses, which increase the BA or therapeutic activity of active pharmaceutical ingredient (API). This review sheds light on the synthesis and classification of bio-enhancers. It also discusses different applications of bio-enhancers like piperine, ginger, quercetin, curcumin, etc. in the treatment of cancer. The review also presents some of the recent advancements in terms of nanocarriers for delivering API combined with bioenhancers.PMID:37957922 | DOI:10.2174/0113892010192038231...
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Pratiksha Vasant Jadhav Naga Jothi Prasath Saurabh Gajbhiye Utkarsha Rane Tejas Girish Agnihotri Shyam Sudhakar Gomte Aakanchha Jain Source Type: research

Evaluation of New Folate Receptor-mediated Mitoxantrone Targeting Liposomes In vitro
CONCLUSION: By modifying folic acid on the surface of liposomes, tumor cells with high expression of folic acid receptors can be effectively targeted, thereby increasing the enrichment of intracellular drugs and improving efficacy. It can also change the delivery pathway, increase the amount of drug entering resistant tumor cells, and overcome resistance.PMID:37957921 | DOI:10.2174/0113892010258845231101091359 (Source: Current Pharmaceutical Biotechnology)
Source: Current Pharmaceutical Biotechnology - November 14, 2023 Category: Biotechnology Authors: Tianjiao Wen Yuan Gao Ying Zheng Bin Shan Cong Song Yahui An Jingxia Cui Source Type: research